ROXAVII Trademark

Trademark Overview

On Tuesday, December 4, 2018, a trademark application was filed for ROXAVII with the United States Patent and Trademark Office. The USPTO has given the ROXAVII trademark a serial number of 88215933. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 6, 2022. This trademark is owned by Biomarin Pharmaceutical Inc.. The ROXAVII trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of genetic diseases and disorders
roxavii

General Information

Serial Number88215933
Word MarkROXAVII
Filing DateTuesday, December 4, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 6, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 5, 2019

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of genetic diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 21, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBiomarin Pharmaceutical Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNovato, CA 94949
Party NameBiomarin Pharmaceutical Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNovato, CA 94949

Trademark Events

Event DateEvent Description
Monday, June 6, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 6, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, October 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 19, 2021SOU EXTENSION 5 GRANTED
Tuesday, October 12, 2021SOU EXTENSION 5 FILED
Monday, October 18, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 12, 2021TEAS EXTENSION RECEIVED
Friday, April 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 28, 2021SOU EXTENSION 4 GRANTED
Wednesday, April 28, 2021SOU EXTENSION 4 FILED
Wednesday, April 28, 2021TEAS EXTENSION RECEIVED
Thursday, October 22, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 20, 2020SOU EXTENSION 3 GRANTED
Tuesday, October 20, 2020SOU EXTENSION 3 FILED
Tuesday, October 20, 2020TEAS EXTENSION RECEIVED
Wednesday, April 29, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 27, 2020SOU EXTENSION 2 GRANTED
Monday, April 27, 2020SOU EXTENSION 2 FILED
Monday, April 27, 2020TEAS EXTENSION RECEIVED
Thursday, October 10, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 8, 2019SOU EXTENSION 1 GRANTED
Tuesday, October 8, 2019SOU EXTENSION 1 FILED
Tuesday, October 8, 2019TEAS EXTENSION RECEIVED
Tuesday, April 30, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 5, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 5, 2019PUBLISHED FOR OPPOSITION
Wednesday, February 13, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 24, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 22, 2019ASSIGNED TO EXAMINER
Friday, December 21, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 7, 2018NEW APPLICATION ENTERED

Related Keywords

roxavii diseases disorders genetic treatment preparations pharmaceutical